Barclays’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Sell |
18,759
-109,819
| -85% | -$93.7K | ﹤0.01% | 4105 |
|
|
2025
Q1 | $87K | Sell |
128,578
-63,376
| -33% | -$42.9K | ﹤0.01% | 3736 |
|
|
2024
Q4 | $181K | Buy |
191,954
+24,236
| +14% | +$22.9K | ﹤0.01% | 3566 |
|
|
2024
Q3 | $255K | Buy |
167,718
+123,683
| +281% | +$188K | ﹤0.01% | 3364 |
|
|
2024
Q2 | $53K | Buy |
+44,035
| New | +$53K | ﹤0.01% | 3649 |
|
|
2022
Q3 | – | Sell |
-100
| Closed | – | – | 4630 |
|
|
2022
Q2 | $0 | Sell |
100
-18,992
| -99% | – | ﹤0.01% | 4699 |
|
|
2022
Q1 | $24K | Sell |
19,092
-122,908
| -87% | -$155K | ﹤0.01% | 4274 |
|
|
2021
Q4 | $227K | Buy |
142,000
+94,190
| +197% | +$151K | ﹤0.01% | 2792 |
|
|
2021
Q3 | $156K | Buy |
47,810
+24,740
| +107% | +$80.7K | ﹤0.01% | 3078 |
|
|
2021
Q2 | $145K | Sell |
23,070
-42,624
| -65% | -$268K | ﹤0.01% | 3008 |
|
|
2021
Q1 | $139K | Buy |
65,694
+53,872
| +456% | +$114K | ﹤0.01% | 3263 |
|
|
2020
Q4 | $11K | Hold |
11,822
| – | – | ﹤0.01% | 3435 |
|
|
2020
Q3 | $29K | Buy |
+11,822
| New | +$29K | ﹤0.01% | 3433 |
|
|
2019
Q4 | – | Sell |
-50
| Closed | – | – | 3856 |
|
|
2019
Q3 | $0 | Sell |
50
-5,500
| -99% | – | ﹤0.01% | 4118 |
|
|
2019
Q2 | $14K | Sell |
5,550
-1,684
| -23% | -$4.25K | ﹤0.01% | 3995 |
|
|
2019
Q1 | $25K | Sell |
7,234
-25,150
| -78% | -$86.9K | ﹤0.01% | 3859 |
|
|
2018
Q4 | $33K | Buy |
+32,384
| New | +$33K | ﹤0.01% | 3271 |
|
|
2018
Q2 | – | Sell |
-161,100
| Closed | -$72K | – | 4182 |
|
|
2018
Q1 | $72K | Buy |
+161,100
| New | +$72K | ﹤0.01% | 3320 |
|
|
2017
Q2 | – | Sell |
-2,020
| Closed | -$2K | – | 3859 |
|
|
2017
Q1 | $2K | Buy |
+2,020
| New | +$2K | ﹤0.01% | 3762 |
|
|
2013
Q3 | – | Sell |
-2,700
| Closed | -$14K | – | 4134 |
|
|
2013
Q2 | $14K | Buy |
+2,700
| New | +$14K | ﹤0.01% | 3795 |
|